LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer
Clinical trial NCT01685138 · COMPLETED
Trial details
- NCT number
- NCT01685138
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-20
- Primary completion
- 2018-01-22
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.